 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Topoisomerase
|
PDB id
|
|
|
|
1bjt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.99.1.3
- Dna topoisomerase (ATP-hydrolyzing).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP-dependent breakage, passage and rejoining of double-stranded DNA.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
chromosome
|
1 term
|
 |
|
Biological process
|
DNA metabolic process
|
3 terms
|
 |
|
Biochemical function
|
DNA binding
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
6:322-326
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
|
|
D.Fass,
C.E.Bogden,
J.M.Berger.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Type II DNA topoisomerases mediate the passage of one DNA duplex through a
transient break in another, an event essential for chromosome segregation and
cell viability. The active sites of the type II topoisomerase dimer associate
covalently with the DNA break-points and must separate by at least the width of
the second DNA duplex to accommodate transport. A new structure of the
Saccharomyces cerevisiae topoisomerase II DNA-binding and cleavage core suggests
that in addition to conformational changes in the DNA-opening platform, a
dramatic reorganization of accessory domains may occur during catalysis. These
conformational differences have implications for both the DNA-breaking and
duplex-transport events in the topo II reaction mechanism, suggest a mechanism
by which two distinct drug-resistance loci interact, and illustrate the scope of
structural changes in the cycling of molecular machines.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Stereo diagrams of the B' domains, and side views in
the context of the topo II DNA-binding and cleavage core. a,
T2O B' orientation. Each B' hook (orange) packs near the
opposite active-site tyrosine (ball-and-stick). The Rossmann
fold (red) makes limited contacts to the A' shoulder of its own
protomer. b, T2M orientation. The associations seen in T2O are
reversed such that the B' hook packs against the A' head of its
own protomer, while the Rossmann fold contacts the opposite
shoulder. In the side view, the B' domains have partially
exposed the DNA-binding groove at the top of the A'
subfragments. Within the B' domains themselves, a modest hinge
motion changes the relative positions of the hook and Rossmann
fold between T2O and T2M. c, Model for the orientation of the B'
domains in a T2C-type topo II structure^14. In this model,
conserved acidic residues in the B' domains lie close to the
active-site tyrosines. In the side view, the DNA-binding groove
is completely exposed.
|
 |
Figure 4.
Figure 4. Schematic illustration of a proposed B' domain
rotation within the global catalytic mechanism. The topo II
'C' state is based on the GyrA A' structure^12 and the
relationship between domain I and the active-site tyrosine
observed in E. coli DNA topoisomerase I^14, ^18. This state is
proposed to bind the uncleaved G segment and promote DNA
cleavage. The 'M' conformations are based on T2M and represents
a DNA-cleaved and partially opened state of the A' subfragments.
Rotation of the B' domains may aid transport of the T segment as
they approach the T2O conformation. The 'O' state represents a
fully open A' arrangement with the T segment stored in the
central hole^11. The B' subfragments are red and orange, and the
A' subfragments are blue. The ATPase domains are indicated in
yellow, and are absent from the 'M' panel for clarity.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(1999,
6,
322-326)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.J.Schoeffler,
A.P.May,
and
J.M.Berger
(2010).
A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.
|
| |
Nucleic Acids Res, 38,
7830-7844.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.H.Schmidt,
A.B.Burgin,
J.E.Deweese,
N.Osheroff,
and
J.M.Berger
(2010).
A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.
|
| |
Nature, 465,
641-644.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Sissi,
and
M.Palumbo
(2010).
In front of and behind the replication fork: bacterial type IIA topoisomerases.
|
| |
Cell Mol Life Sci, 67,
2001-2024.
|
 |
|
|
|
|
 |
G.L.Chee,
J.C.Yalowich,
A.Bodner,
X.Wu,
and
B.B.Hasinoff
(2010).
A diazirine-based photoaffinity etoposide probe for labeling topoisomerase II.
|
| |
Bioorg Med Chem, 18,
830-838.
|
 |
|
|
|
|
 |
J.Piton,
S.Petrella,
M.Delarue,
G.André-Leroux,
V.Jarlier,
A.Aubry,
and
C.Mayer
(2010).
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
|
| |
PLoS One, 5,
e12245.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Xie
(2010).
Dynamics of strand passage catalyzed by topoisomerase II.
|
| |
Eur Biophys J, 39,
1251-1259.
|
 |
|
|
|
|
 |
A.Gubaev,
M.Hilbert,
and
D.Klostermeier
(2009).
The DNA-gate of Bacillus subtilis gyrase is predominantly in the closed conformation during the DNA supercoiling reaction.
|
| |
Proc Natl Acad Sci U S A, 106,
13278-13283.
|
 |
|
|
|
|
 |
G.Fu,
J.Wu,
W.Liu,
D.Zhu,
Y.Hu,
J.Deng,
X.E.Zhang,
L.Bi,
and
D.C.Wang
(2009).
Crystal structure of DNA gyrase B' domain sheds lights on the mechanism for T-segment navigation.
|
| |
Nucleic Acids Res, 37,
5908-5916.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.L.Nitiss
(2009).
DNA topoisomerase II and its growing repertoire of biological functions.
|
| |
Nat Rev Cancer, 9,
327-337.
|
 |
|
|
|
|
 |
N.De Jonge,
A.Garcia-Pino,
L.Buts,
S.Haesaerts,
D.Charlier,
K.Zangger,
L.Wyns,
H.De Greve,
and
R.Loris
(2009).
Rejuvenation of CcdB-poisoned gyrase by an intrinsically disordered protein domain.
|
| |
Mol Cell, 35,
154-163.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.R.Collins,
G.G.Hammes,
and
T.S.Hsieh
(2009).
Analysis of the eukaryotic topoisomerase II DNA gate: a single-molecule FRET and structural perspective.
|
| |
Nucleic Acids Res, 37,
712-720.
|
 |
|
|
|
|
 |
X.S.Pan,
K.A.Gould,
and
L.M.Fisher
(2009).
Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
|
| |
Antimicrob Agents Chemother, 53,
3822-3831.
|
 |
|
|
|
|
 |
Y.S.Liu,
Y.Fang,
and
K.Ramani
(2009).
Using least median of squares for structural superposition of flexible proteins.
|
| |
BMC Bioinformatics, 10,
29.
|
 |
|
|
|
|
 |
A.J.Schoeffler,
and
J.M.Berger
(2008).
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.
|
| |
Q Rev Biophys, 41,
41.
|
 |
|
|
|
|
 |
K.Drlica,
M.Malik,
R.J.Kerns,
and
X.Zhao
(2008).
Quinolone-mediated bacterial death.
|
| |
Antimicrob Agents Chemother, 52,
385-392.
|
 |
|
|
|
|
 |
F.Mueller-Planitz,
and
D.Herschlag
(2007).
DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity.
|
| |
Nucleic Acids Res, 35,
3764-3773.
|
 |
|
|
|
|
 |
J.C.Wang
(2007).
Unlocking and opening a DNA gate.
|
| |
Proc Natl Acad Sci U S A, 104,
4773-4774.
|
 |
|
|
|
|
 |
L.Costenaro,
J.G.Grossmann,
C.Ebel,
and
A.Maxwell
(2007).
Modular structure of the full-length DNA gyrase B subunit revealed by small-angle X-ray scattering.
|
| |
Structure, 15,
329-339.
|
 |
|
|
|
|
 |
R.D.Smiley,
T.R.Collins,
G.G.Hammes,
and
T.S.Hsieh
(2007).
Single-molecule measurements of the opening and closing of the DNA gate by eukaryotic topoisomerase II.
|
| |
Proc Natl Acad Sci U S A, 104,
4840-4845.
|
 |
|
|
|
|
 |
B.Taneja,
A.Patel,
A.Slesarev,
and
A.Mondragón
(2006).
Structure of the N-terminal fragment of topoisomerase V reveals a new family of topoisomerases.
|
| |
EMBO J, 25,
398-408.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Salceda,
X.Fernández,
and
J.Roca
(2006).
Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
|
| |
EMBO J, 25,
2575-2583.
|
 |
|
|
|
|
 |
K.L.Gilroy,
C.Leontiou,
K.Padget,
J.H.Lakey,
and
C.A.Austin
(2006).
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.
|
| |
Nucleic Acids Res, 34,
1597-1607.
|
 |
|
|
|
|
 |
M.Oram,
A.A.Travers,
A.J.Howells,
A.Maxwell,
and
M.L.Pato
(2006).
Dissection of the bacteriophage Mu strong gyrase site (SGS): significance of the SGS right arm in Mu biology and DNA gyrase mechanism.
|
| |
J Bacteriol, 188,
619-632.
|
 |
|
|
|
|
 |
H.Wei,
A.J.Ruthenburg,
S.K.Bechis,
and
G.L.Verdine
(2005).
Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase.
|
| |
J Biol Chem, 280,
37041-37047.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.H.Tran,
G.A.Jacoby,
and
D.C.Hooper
(2005).
Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
|
| |
Antimicrob Agents Chemother, 49,
118-125.
|
 |
|
|
|
|
 |
J.N.Forkey,
M.E.Quinlan,
and
Y.E.Goldman
(2005).
Measurement of single macromolecule orientation by total internal reflection fluorescence polarization microscopy.
|
| |
Biophys J, 89,
1261-1271.
|
 |
|
|
|
|
 |
L.Costenaro,
J.G.Grossmann,
C.Ebel,
and
A.Maxwell
(2005).
Small-angle X-ray scattering reveals the solution structure of the full-length DNA gyrase a subunit.
|
| |
Structure, 13,
287-296.
|
 |
|
|
|
|
 |
L.Sari,
and
I.Andricioaei
(2005).
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation.
|
| |
Nucleic Acids Res, 33,
6621-6634.
|
 |
|
|
|
|
 |
J.Roca
(2004).
The path of the DNA along the dimer interface of topoisomerase II.
|
| |
J Biol Chem, 279,
25783-25788.
|
 |
|
|
|
|
 |
J.V.Walker,
K.C.Nitiss,
L.H.Jensen,
C.Mayne,
T.Hu,
P.B.Jensen,
M.Sehested,
T.Hsieh,
and
J.L.Nitiss
(2004).
A mutation in human topoisomerase II alpha whose expression is lethal in DNA repair-deficient yeast cells.
|
| |
J Biol Chem, 279,
25947-25954.
|
 |
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2004).
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
|
| |
Annu Rev Biophys Biomol Struct, 33,
95.
|
 |
|
|
|
|
 |
K.D.Corbett,
R.K.Shultzaberger,
and
J.M.Berger
(2004).
The C-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold.
|
| |
Proc Natl Acad Sci U S A, 101,
7293-7298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Gruger,
J.L.Nitiss,
A.Maxwell,
E.L.Zechiedrich,
P.Heisig,
S.Seeber,
Y.Pommier,
and
D.Strumberg
(2004).
A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
|
| |
Antimicrob Agents Chemother, 48,
4495-4504.
|
 |
|
|
|
|
 |
V.H.Oestergaard,
L.Bjergbaek,
C.Skouboe,
L.Giangiacomo,
B.R.Knudsen,
and
A.H.Andersen
(2004).
The transducer domain is important for clamp operation in human DNA topoisomerase IIalpha.
|
| |
J Biol Chem, 279,
1684-1691.
|
 |
|
|
|
|
 |
D.Ince,
X.Zhang,
L.C.Silver,
and
D.C.Hooper
(2003).
Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.
|
| |
Antimicrob Agents Chemother, 47,
274-282.
|
 |
|
|
|
|
 |
F.Sifaoui,
V.Lamour,
E.Varon,
D.Moras,
and
L.Gutmann
(2003).
ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.
|
| |
J Bacteriol, 185,
6137-6146.
|
 |
|
|
|
|
 |
Q.A.Khan,
G.Kohlhagen,
R.Marshall,
C.A.Austin,
G.P.Kalena,
H.Kroth,
J.M.Sayer,
D.M.Jerina,
and
Y.Pommier
(2003).
Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents.
|
| |
Proc Natl Acad Sci U S A, 100,
12498-12503.
|
 |
|
|
|
|
 |
D.Ince,
X.Zhang,
L.C.Silver,
and
D.C.Hooper
(2002).
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.
|
| |
Antimicrob Agents Chemother, 46,
3370-3380.
|
 |
|
|
|
|
 |
D.Strumberg,
J.L.Nitiss,
J.Dong,
J.Walker,
M.C.Nicklaus,
K.W.Kohn,
J.G.Heddle,
A.Maxwell,
S.Seeber,
and
Y.Pommier
(2002).
Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action.
|
| |
Antimicrob Agents Chemother, 46,
2735-2746.
|
 |
|
|
|
|
 |
J.Heddle,
and
A.Maxwell
(2002).
Quinolone-binding pocket of DNA gyrase: role of GyrB.
|
| |
Antimicrob Agents Chemother, 46,
1805-1815.
|
 |
|
|
|
|
 |
K.D.Bromberg,
C.Hendricks,
A.B.Burgin,
and
N.Osheroff
(2002).
Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanism.
|
| |
J Biol Chem, 277,
31201-31206.
|
 |
|
|
|
|
 |
S.Trigueros,
and
J.Roca
(2002).
A GyrB-GyrA fusion protein expressed in yeast cells is able to remove DNA supercoils but cannot substitute eukaryotic topoisomerase II.
|
| |
Genes Cells, 7,
249-257.
|
 |
|
|
|
|
 |
V.Lamour,
L.Hoermann,
J.M.Jeltsch,
P.Oudet,
and
D.Moras
(2002).
An open conformation of the Thermus thermophilus gyrase B ATP-binding domain.
|
| |
J Biol Chem, 277,
18947-18953.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Janoir,
E.Varon,
M.D.Kitzis,
and
L.Gutmann
(2001).
New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones.
|
| |
Antimicrob Agents Chemother, 45,
952-955.
|
 |
|
|
|
|
 |
D.C.Hooper
(2001).
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
|
| |
Clin Infect Dis, 32,
S9.
|
 |
|
|
|
|
 |
F.J.del Castillo,
I.del Castillo,
and
F.Moreno
(2001).
Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
|
| |
J Bacteriol, 183,
2137-2140.
|
 |
|
|
|
|
 |
F.M.Barnard,
and
A.Maxwell
(2001).
Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
|
| |
Antimicrob Agents Chemother, 45,
1994-2000.
|
 |
|
|
|
|
 |
J.J.Champoux
(2001).
DNA topoisomerases: structure, function, and mechanism.
|
| |
Annu Rev Biochem, 70,
369-413.
|
 |
|
|
|
|
 |
L.M.Weigel,
G.J.Anderson,
R.R.Facklam,
and
F.C.Tenover
(2001).
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
|
| |
Antimicrob Agents Chemother, 45,
3517-3523.
|
 |
|
|
|
|
 |
T.J.Dougherty,
D.Beaulieu,
and
J.F.Barrett
(2001).
New quinolones and the impact on resistance.
|
| |
Drug Discov Today, 6,
529-536.
|
 |
|
|
|
|
 |
D.J.Bast,
D.E.Low,
C.L.Duncan,
L.Kilburn,
L.A.Mandell,
R.J.Davidson,
and
J.C.de Azavedo
(2000).
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
|
| |
Antimicrob Agents Chemother, 44,
3049-3054.
|
 |
|
|
|
|
 |
J.Dong,
J.Walker,
and
J.L.Nitiss
(2000).
A mutation in yeast topoisomerase II that confers hypersensitivity to multiple classes of topoisomerase II poisons.
|
| |
J Biol Chem, 275,
7980-7987.
|
 |
|
|
|
|
 |
K.L.West,
E.L.Meczes,
R.Thorn,
R.M.Turnbull,
R.Marshall,
and
C.A.Austin
(2000).
Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage.
|
| |
Biochemistry, 39,
1223-1233.
|
 |
|
|
|
|
 |
S.K.Morris,
C.L.Baird,
and
J.E.Lindsley
(2000).
Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193.
|
| |
J Biol Chem, 275,
2613-2618.
|
 |
|
|
|
|
 |
C.L.Baird,
T.T.Harkins,
S.K.Morris,
and
J.E.Lindsley
(1999).
Topoisomerase II drives DNA transport by hydrolyzing one ATP.
|
| |
Proc Natl Acad Sci U S A, 96,
13685-13690.
|
 |
|
|
|
|
 |
D.Strumberg,
J.L.Nitiss,
J.Dong,
K.W.Kohn,
and
Y.Pommier
(1999).
Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions.
|
| |
J Biol Chem, 274,
28246-28255.
|
 |
|
|
|
|
 |
M.D.Nichols,
K.DeAngelis,
J.L.Keck,
and
J.M.Berger
(1999).
Structure and function of an archaeal topoisomerase VI subunit with homology to the meiotic recombination factor Spo11.
|
| |
EMBO J, 18,
6177-6188.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.K.Morris,
and
J.E.Lindsley
(1999).
Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP.
|
| |
J Biol Chem, 274,
30690-30696.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|